You are On
Home Blog Latest News on Generic Viagra

Latest News on Generic Viagra

Generic Viagra is prepared by the composition of a well known chemical sildenafil citrate and is used to deal with discrepancies related to erectile dysfunction. This medication is known work at its best when consumed within the recommended dosage. There are various pharmacies that have been going through great disputes and are also facing an immense competition related to the generic formula. This medication is now well known in the pharmaceutical market as the best and affordable curing aid. Many men across the globe have noticed and reported positive results after the consumption of the generic version.

There are various generic drug makers throughout the world who manufacture quality generic medicines, but they face a rave attempt from the father of the branded drug Pfizer which has hurdled the production of this drug in the generic form. Pfizer has also reported to file a suit in the US district court and have extended their patency on the original drug up to October 2019. The pharmacies of the generic medicines have applied for approval from FDA for the manufacture of the generic formula but they are all put on a hold for a while.

Viagra seems to work on the most sensitive anatomy of the human body and it is always advised by the physicians that the individual should consume this medication with full knowledge and take the required precautionary steps to avoid any kind of severe side effects. Sildenafil citrate is the major chemical which is used to manufacture the blue pill and it is advised that the individual should have complete knowledge on the side effects of this drug. The blue pill should be consumed only once in 24 hours and the exceeded dosage may lead to dire consequences.

If you notice the popularity of this drug then the sales of Viagra speak great figures. The reason Pfizer has been protecting the patency is because they earn a great deal of income from the sale of Viagra. It has also been reported that the lawsuit filed between Pfizer and other generic drug manufacturer has been kept on hold and it is expected to resolve by 2013. Till then the generic drug manufactures have to wait and cannot sell their medications without proper approval from the court.

Recently Pfizer had lost its patency over its cholesterol reducing drug known as Lipitor and the generic manufacturers did not delay on this deal and started producing the generic form of Lipitor. This sounds to be legal as the generic drug manufacturers started selling the generic form of the drug only after the patent was released from the original manufacturer. The patency of Lipitor expired in 2011.